Pharmaceuticals US

US Essential Tremor Treatment Market Analysis, 2024–2034

US Essential Tremor Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Severity, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $270.6 Mn Estimated value
Estimate 2025 $287.1 Mn 41% of the global market
Projected 2034 $489.1 Mn 70.4% Adds $202.1 Mn over 9 forecast years
CAGR 2025–2034 6.1% Faster than 51% of 180 Pharmaceuticals markets here
Key players 5
  • US is 41.02% of the global market.
  • In North America, the largest is US (this report) at $287.1 Mn.
  • Fastest growing: Canada at 7.8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$202.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Essential Tremor Treatment Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $270.6 Mn — —
2025 (base) $287.1 Mn +$16.5 Mn —
2026 (forecast) $304.6 Mn +$17.5 Mn +6.1%
2027 (forecast) $323.1 Mn +$18.6 Mn +12.6%
2028 (forecast) $342.9 Mn +$19.7 Mn +19.4%
2029 (forecast) $363.8 Mn +$20.9 Mn +26.7%
2030 (forecast) $386.0 Mn +$22.2 Mn +34.5%
2031 (forecast) $409.5 Mn +$23.5 Mn +42.7%
2032 (forecast) $434.5 Mn +$25.0 Mn +51.4%
2033 (forecast) $461.0 Mn +$26.5 Mn +60.6%
2034 (forecast) $489.1 Mn +$28.1 Mn +70.4%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

The US Essential Tremor Treatment Market Analysis Executive Summary

Essential tremor treatments reduce shaking with medicines, focused ultrasound, brain stimulation and wearable devices.

Key segments of the essential Tremor Treatment market include treatment (Medication, Focused Ultrasound and Deep Brain Stimulation) and severity (Mild, Moderate and Severe).

US Essential Tremor Treatment Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the essential Tremor Treatment market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the essential Tremor Treatment market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the essential Tremor Treatment market.

Competitive Landscape for Essential Tremor Treatment Market in US

The essential Tremor Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Essential Tremor Treatment Market in US

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for essential Tremor Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Essential Tremor Treatment right now, from free public sources.

Clinical trials

44 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Insightec 4 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Boston Scientific Corporation 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Encora, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Essential Tremor Treatment in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Essential Tremor Treatment are running in the US?
44 studies are recruiting, active or about to start in the US.[4]
How much research is published on Essential Tremor Treatment?
PubMed lists 945 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Back to Catalogue

Related Pharmaceuticals reports in US

See all

Related on brain and nerves

See the topic